Christensen A P, Oei T P
Department of Psychology, University of Queensland, Australia.
J Affect Disord. 1995 Jan 11;33(1):47-55. doi: 10.1016/0165-0327(94)00072-h.
Comparisons were made between the premenstrual changes reported by nontreatment-seekers (NTS) (n = 32) and those of treatment-seekers (TS) (n = 52). The Premenstrual Assessment Form Luteal Phase and Follicular Phase versions were completed and the Beck Depression Inventory, the Automatic Thoughts Questionnaire and the State-Trait Anxiety Inventory were completed at both the luteal and follicular phases. Prospective daily ratings were made for two treatment cycles on the Daily Ratings Form and TS were screened for a mood-disorder history. Using the commonly cited 30% decrease in dysphoric levels from the pre- to postmenstrual phases as the criterion of prospective confirmation, women with prospectively confirmed dysphoria (PMD +) were not significantly more symptomatic than those without prospective dysphoric confirmation (PMD -). However, TS were more symptomatic than NTS on measures of depression, anxiety and frequency of negative automatic thoughts but not on mood behaviour and physical changes reflected in the PAF scales. No demographic differences were found between TS and NTS. Results did not support the issue of requiring 'confirmation' of self-reports within a help-seeking group or the use of the 30% criterion in particular. Findings further suggest that the 95-item PAF may be inadequate in differentiating TS from others.
对未寻求治疗者（NTS）（n = 32）和寻求治疗者（TS）（n = 52）报告的经前变化进行了比较。完成了经前评估表黄体期和卵泡期版本，并在黄体期和卵泡期完成了贝克抑郁量表、自动思维问卷和状态-特质焦虑量表。在每日评分表上对两个治疗周期进行了前瞻性每日评分，并对TS进行了情绪障碍病史筛查。以前到经后期烦躁水平降低30%作为前瞻性确认的标准，经前瞻性确认烦躁的女性（PMD +）并不比未得到前瞻性烦躁确认的女性（PMD -）症状更明显。然而，在抑郁、焦虑和消极自动思维频率的测量上，TS比NTS症状更明显，但在经前评估表量表所反映的情绪行为和身体变化方面并非如此。TS和NTS之间未发现人口统计学差异。结果不支持在寻求帮助的群体中需要对自我报告进行“确认”这一问题，尤其不支持使用30%这一标准。研究结果进一步表明，95项经前评估表可能不足以区分TS和其他人。
